文献速递神经儿科影像MR

儿童弥漫性中线胶质瘤伴组蛋白H3-K27M突变的扩散特征:基于表观扩散系数直方图分析

Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-11-06

本研究纳入31例儿童弥漫性中线胶质瘤患者,采用基于体素的三维全肿瘤测量方法评估ADC直方图参数。结果显示H3-K27M突变型与野生型肿瘤的ADC直方图参数无差异,但生存期<1年患者的中位ADC低于生存期>1年患者,且弥漫性中线胶质瘤平均ADC高于半球胶质母细胞瘤。

要点

  • H3-K27M突变型与野生型弥漫性中线胶质瘤的ADC直方图参数无显著差异。
  • 生存期<1年患者的中位ADC(1.10×10⁻³mm²/s)低于生存期>1年患者(1.46×10⁻³mm²/s),P<.06。
  • 弥漫性中线胶质瘤平均ADC为1.28×10⁻³mm²/s,高于半球胶质母细胞瘤的0.86×10⁻³mm²/s,P<.05。

关键影像表现/征象

  • 18例为幕下、13例为幕上中线结构弥漫性胶质瘤,23例(74%)携带H3-K27M突变。
  • 突变型与野生型肿瘤的ADC直方图参数(均值、中位数、最小值、最大值、百分位数)无差异。
  • 基于肿瘤位置的亚组分析亦未发现直方图描述性统计量的差异。

诊断标准与关键数值

  • H3-K27M突变型与野生型弥漫性中线胶质瘤ADC直方图参数无差异。
  • 生存期<1年患者中位ADC为1.10×10⁻³mm²/s(95%CI,0.90-1.30),生存期>1年患者为1.46×10⁻³mm²/s(95%CI,1.19-1.67),P<.06。
  • 弥漫性中线胶质瘤平均ADC为1.28×10⁻³mm²/s(95%CI,1.21-1.34),半球胶质母细胞瘤为0.86×10⁻³mm²/s(95%CI,0.69-1.01),P<.05。

临床应用与阅片要点

  • ADC直方图分析不能用于鉴别H3-K27M突变型与野生型弥漫性中线胶质瘤。
  • 较低的ADC值可能与诊断后1年较低的生存率相关,可为临床病程预期提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Diffuse midline gliomas with histone H3 K27M mutation are biologically aggressive tumors with poor prognosis defined as a new diagnostic entity in the 2016 World Health Organization Classification of Tumors of the Central Nervous System. There are no qualitative imaging differences (enhancement, border, or central necrosis) between histone H3 wildtype and H3 K27M-mutant diffuse midline gliomas. Herein, we evaluated the utility of diffusion-weighted imaging to distinguish H3 K27M-mutant from histone H3 wildtype diffuse midline gliomas.

MATERIALS AND METHODS: We identified 31 pediatric patients (younger than 21 years of age) with diffuse gliomas centered in midline structures that had undergone assessment for histone H3 K27M mutation. We measured ADC within these tumors using a voxel-based 3D whole-tumor measurement method.

RESULTS: Our cohort included 18 infratentorial and 13 supratentorial diffuse gliomas centered in midline structures. Twenty-three (74%) tumors carried H3-K27M mutations. There was no difference in ADC histogram parameters (mean, median, minimum, maximum, percentiles) between mutant and wild-type tumors. Subgroup analysis based on tumor location also did not identify a difference in histogram descriptive statistics. Patients who survived <1 year after diagnosis had lower median ADC (1.10 × 10-3mm2/s; 95% CI, 0.90-1.30) compared with patients who survived >1 year (1.46 × 10-3mm2/s; 95% CI, 1.19-1.67; P < .06). Average ADC values for diffuse midline gliomas were 1.28 × 10-3mm2/s (95% CI, 1.21-1.34) and 0.86 × 10-3mm2/s (95% CI, 0.69-1.01) for hemispheric glioblastomas with P < .05.

CONCLUSIONS: Although no statistically significant difference in diffusion characteristics was found between H3-K27M mutant and H3 wildtype diffuse midline gliomas, lower diffusivity corresponds to a lower survival rate at 1 year after diagnosis. These findings can have an impact on the anticipated clinical course for this patient population and offer providers and families guidance on clinical outcomes.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Aboian MS, Tong E, Solomon DA, et al. Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis. AJNR Am J Neuroradiol. 2019. PMID: 31694820. doi:10.3174/ajnr.A6302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。